Page last updated: 2024-08-22

cupric chloride and disulfiram

cupric chloride has been researched along with disulfiram in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, SH; Liang, YC; Lin, JK; Lin-Shiau, SY; Liu, SH1
Babushkin, T; Hait-Darshan, R; Malik, Z1
An, H; Cho, TM; Cho, Y; Kim, JY; Lee, N; Oh, E; Seo, JH; Sung, D1
An, H; Cho, TM; Cho, Y; Kim, JY; Kim, YJ; Lee, N; Oh, E; Seo, JH; Sung, D1
Al-Tamimi, J; Alhazza, IM; Aman, S; Ebaid, H; Hassan, I; Khan, AA; Qamar, W; Rady, AM1

Other Studies

5 other study(ies) available for cupric chloride and disulfiram

ArticleYear
Oxidative stress and c-Jun-amino-terminal kinase activation involved in apoptosis of primary astrocytes induced by disulfiram-Cu(2+) complex.
    European journal of pharmacology, 2001, Mar-02, Volume: 414, Issue:2-3

    Topics: Animals; Animals, Newborn; Apoptosis; Astrocytes; Caspase 3; Caspases; Cells, Cultured; Cerebral Cortex; Copper; Disulfiram; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Free Radicals; Glutathione; JNK Mitogen-Activated Protein Kinases; Membrane Potentials; Mitogen-Activated Protein Kinases; Oxidative Stress; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar

2001
Regulation of heme synthesis and proteasomal activity by copper: possible implications for Wilson's disease.
    Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2009, Volume: 28, Issue:3

    Topics: Adenosine Triphosphatases; Carcinoma, Hepatocellular; Cation Transport Proteins; Cell Line, Tumor; Cell Survival; Copper; Copper-Transporting ATPases; Disulfiram; Down-Regulation; Enzyme Inhibitors; Heme; Hepatocytes; Hepatolenticular Degeneration; Humans; Hydroxymethylbilane Synthase; Liver Neoplasms; Porphobilinogen Synthase; Proteasome Endopeptidase Complex; Protoporphyrins; Reactive Oxygen Species; Ubiquitin

2009
Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.
    Cancer letters, 2016, 08-28, Volume: 379, Issue:1

    Topics: Acetaldehyde Dehydrogenase Inhibitors; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Copper; Cyclin-Dependent Kinase Inhibitor p27; Disulfiram; Dose-Response Relationship, Drug; Female; Humans; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Phenotype; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Retinal Dehydrogenase; Signal Transduction; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays

2016
Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.
    Cancer letters, 2017, 02-01, Volume: 386

    Topics: Animals; Anoikis; Antineoplastic Agents; Calpain; Cell Line, Tumor; Cell Movement; Cell Proliferation; Copper; Cytoskeleton; Disulfiram; Dose-Response Relationship, Drug; Enzyme Activation; Female; Focal Adhesions; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Proteolysis; Signal Transduction; Time Factors; Triple Negative Breast Neoplasms; Tumor Burden; Vimentin; Xenograft Model Antitumor Assays

2017
Restrained management of copper level enhances the antineoplastic activity of imatinib in vitro and in vivo.
    Scientific reports, 2018, 01-26, Volume: 8, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Survival; Chemotherapy, Adjuvant; Copper; Disulfiram; Drug Synergism; Imatinib Mesylate; Metabolism; Neoplasms, Experimental; Rats; Treatment Outcome

2018